The Contrast Media Injectors Market is projected to grow significantly in the coming years due to the rising demand for advanced imaging diagnostics in order to reduce the risk of cancer. Contrast media are injected into the patient’s body to enhance the visibility of the X-ray, CT, MRI, and ultrasound images. This helps medical professionals to identify tumors, blockages, and other abnormalities. The growing awareness about the benefits of these imaging techniques, along with the growing prevalence of cancer, is driving the demand for contrast media injectors.

Currently, Contrast Media Injectors Market size is estimated to be USD 1.3 billion in 2020 and projected to reach USD 1.9 billion by 2025, at a CAGR of 7.4% between 2020 and 2025.Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the growth of the contrast media injectors market. However, the high cost of contrast media injectors and consumables & accessories is restraining the growth of the market to a certain extent.

The increasing number of medical imaging centers, the growing geriatric population, the rising prevalence of chronic diseases, the rising healthcare expenditure, the increasing demand for minimally invasive procedures, and the increasing adoption of advanced contrast media injectors are some of the key factors driving the global contrast media injectors market. Moreover, the availability of a wide range of contrast media injectors with advanced features, such as automatic contrast injection, real-time monitoring, and multi-modality support, is expected to fuel the demand for contrast media injectors.

Request for assumptions & how numbers were triangulated.

https://www.marketsandmarkets.com/requestsampleNew.asp?id=96046959

The increasing focus on research and development activities to develop advanced contrast media injectors and the introduction of new products are driving the growth of the global contrast media injectors market. Moreover, the growing demand for cost-effective contrast media injectors and the increasing penetration of contrast media injectors in emerging markets are some of the key factors driving the growth of the global contrast media injectors market.

Key Players

The key players in the Contrast Media Injectors Market include Bayer Ag (Germany), Bracco Imaging S.P.A (Italy), Guerbet Group (France), Ulrich GmbH & Co. KG (Germany), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical-Device Technology Co., Ltd. (Sinomdt) (China), APOLLO RT Co. Ltd. (Hongkong), Shenzhen Anke High-Tech Co. Ltd. (China), Shenzen Seacrown Electromechanical Co. Ltd. (China), and Medtron AG (Germany).

However, the availability of alternative imaging techniques and the high cost of contrast media injectors are expected to hamper the growth of the global contrast media injectors market. Nevertheless, the increasing adoption of contrast media injectors in developing countries and the introduction of new products are expected to create lucrative opportunities for the global contrast media injectors market.

Download an Illustrative Overview:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96046959

Recent Developments

In 2018, Bayer (Germany) launched the Medrad Centargo CT injection system for the CT injection segment
In 2019, Guerbet Group partnered with IBM Watson Health for AI in medical imaging to support liver cancer diagnostics, utilizing CT and MRI imaging.
Content Source:

https://www.marketsandmarkets.com/Market-Reports/contrast-injector-market-96046959.html

https://www.prnewswire.com/news-releases/contrast-media-injectors-market-worth-1-9-billion-by-2025--exclusive-report-by-marketsandmarkets-301122760.html